Selasa, 17 April 2012

Drug Choice for Osteoporosis


Drug choice for osteoporosis of have to show ability protect and improve bone mass, taking care of the quality of bone so that lessen bone risk broken, improve thicking of bone or slow down speed of bone omission. 

Drug choice for osteoporosis and another bone disease include :

1. Derivate of Bifosfonat.
Bifosfonat is one of drug choice that can be recommended for osteopororsis because have function prevent damage of bone, taking care of bone mass, and improve density of the backbone and flank bone, and lessen bone risk broken.Derivate of Bifosfonat are Risedronate, Alendronate, Pamidronate, Clodronate,Zoledronate, Ibandronate acid.

2. Selective Estrogen Receptor Modulator ( SERM ).
SERM can improve bone mass but do not have negative effect of estrogen (giving of estrogen long-range will increasing risk of ferocity at mammae anduterus ). Derivate of SERMS is Raloxifene.

3. Metabolite of vitamin D.
Metabolite of vitamin D ( calcitriol and alpha calcidol ) able lessen risk of bone broken as a effect of osteoporosis.

4. Calcitonin.
Calcitonin be recommended to be passed to one who suffer broken backbone accompanied pain. Calcitonin can depress action of osteoclase and inhibit its expenditure.

5. Strontium ranelate.
Strontium Ranelate improve forming of bone like precursor of osteoblas and making collagen, decreasing resorption of bone through decreasing activity of osteoclase.

0 komentar:

Posting Komentar